Halozyme Therapeutics Gross Margin 2010-2025 | HALO
- Halozyme Therapeutics average gross margin for 2024 was 81.33%, a 5.43% increase from 2023.
- Halozyme Therapeutics average gross margin for 2023 was 77.14%, a 4.39% increase from 2022.
- Halozyme Therapeutics average gross margin for 2022 was 80.68%, a 1.63% decline from 2021.
Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.